Cargando…

The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry

OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattes, Malcolm D., Lee, Jennifer C., Metzger, Daniel J., Ashamalla, Hani, Katsoulakis, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302280/
https://www.ncbi.nlm.nih.gov/pubmed/25310855
http://dx.doi.org/10.3802/jgo.2015.26.1.19
_version_ 1782353768133689344
author Mattes, Malcolm D.
Lee, Jennifer C.
Metzger, Daniel J.
Ashamalla, Hani
Katsoulakis, Evangelia
author_facet Mattes, Malcolm D.
Lee, Jennifer C.
Metzger, Daniel J.
Ashamalla, Hani
Katsoulakis, Evangelia
author_sort Mattes, Malcolm D.
collection PubMed
description OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) who underwent complete surgical staging and lymph node dissection. METHODS: Nine hundred seventy-two eligible patients diagnosed between 1998 to 2009 with International Federation of Gynecology and Obstetrics (FIGO) 1988 stage IA-IVA UPSC (n=685) or UCCC (n=287) were identified for analysis. Binomial logistic regression was used to determine risk factors for lymph node metastasis, with the incidence of pelvic and para-aortic lymph node metastases reported for each FIGO primary tumor stage. The Cox proportional hazards regression model was used to determine factors associated with overall survival. RESULTS: FIGO primary tumor stage was the only independent risk factor for lymph node metastasis (p<0.01). The incidence of pelvis-only and para-aortic lymph node involvement according to the FIGO primary tumor stage were as follows: IA (2.3%/3.8%), IB (7.5%/5.2%), IC (22.5%/16.9%), IIA (20.8%/13.2%), IIB (25.7%/14.9%), and III/IV (25.7%/24.3%). Prognostic factors for overall survival included lymph node involvement (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.09 to 1.85; p<0.01), patient age >60 years (HR, 1.70; 95% CI, 1.21 to 2.41; p<0.01), and advanced FIGO primary tumor stage (p<0.01). Tumor grade, histologic subtype, and patient race did not predict for either lymph node metastasis or overall survival. CONCLUSION: There is a high incidence of both pelvic and para-aortic lymph node metastases for FIGO stages IC and above uterine papillary serous and clear cell carcinomas, suggesting a potential role for lymph node-directed therapy for these patients.
format Online
Article
Text
id pubmed-4302280
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-43022802015-01-27 The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry Mattes, Malcolm D. Lee, Jennifer C. Metzger, Daniel J. Ashamalla, Hani Katsoulakis, Evangelia J Gynecol Oncol Original Article OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) who underwent complete surgical staging and lymph node dissection. METHODS: Nine hundred seventy-two eligible patients diagnosed between 1998 to 2009 with International Federation of Gynecology and Obstetrics (FIGO) 1988 stage IA-IVA UPSC (n=685) or UCCC (n=287) were identified for analysis. Binomial logistic regression was used to determine risk factors for lymph node metastasis, with the incidence of pelvic and para-aortic lymph node metastases reported for each FIGO primary tumor stage. The Cox proportional hazards regression model was used to determine factors associated with overall survival. RESULTS: FIGO primary tumor stage was the only independent risk factor for lymph node metastasis (p<0.01). The incidence of pelvis-only and para-aortic lymph node involvement according to the FIGO primary tumor stage were as follows: IA (2.3%/3.8%), IB (7.5%/5.2%), IC (22.5%/16.9%), IIA (20.8%/13.2%), IIB (25.7%/14.9%), and III/IV (25.7%/24.3%). Prognostic factors for overall survival included lymph node involvement (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.09 to 1.85; p<0.01), patient age >60 years (HR, 1.70; 95% CI, 1.21 to 2.41; p<0.01), and advanced FIGO primary tumor stage (p<0.01). Tumor grade, histologic subtype, and patient race did not predict for either lymph node metastasis or overall survival. CONCLUSION: There is a high incidence of both pelvic and para-aortic lymph node metastases for FIGO stages IC and above uterine papillary serous and clear cell carcinomas, suggesting a potential role for lymph node-directed therapy for these patients. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015-01 2015-01-08 /pmc/articles/PMC4302280/ /pubmed/25310855 http://dx.doi.org/10.3802/jgo.2015.26.1.19 Text en Copyright © 2015. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mattes, Malcolm D.
Lee, Jennifer C.
Metzger, Daniel J.
Ashamalla, Hani
Katsoulakis, Evangelia
The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
title The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
title_full The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
title_fullStr The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
title_full_unstemmed The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
title_short The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
title_sort incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the seer registry
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302280/
https://www.ncbi.nlm.nih.gov/pubmed/25310855
http://dx.doi.org/10.3802/jgo.2015.26.1.19
work_keys_str_mv AT mattesmalcolmd theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT leejenniferc theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT metzgerdanielj theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT ashamallahani theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT katsoulakisevangelia theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT mattesmalcolmd incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT leejenniferc incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT metzgerdanielj incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT ashamallahani incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry
AT katsoulakisevangelia incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry